In collaboration with expert pathologists and genetics counsellors, the Association for Molecular Pathology (AMP), AstraZeneca, & MSD have developed educational modules on the importance and methodology behind BRCA testing in early and advanced breast cancer. This Virtual Education Series consists of modules designed to provide training on the theoretical, technical, and practical aspects of diagnostic testing in breast cancer. Modules can be completed in any order.
For each module you will need to complete the following:
- Pre-module assessment
- Webinar Recording
- Module evaluation
- Post-module assessment
Once you complete the pre- module assessment the video will be accessible to view on the page.
Modules
Theory behind BRCA testing in breast cancer
Speaker: Michelle Shiller, DO, AP/CP, MGP
How to perform germline BRCA testing in breast cancer
Speaker: Diana Mandelker, MD, PhD
Best laboratory practice for molecular sequencing in breast cancer
Speaker: Eric Konnick, MD, MS
Genetic consenting
Speaker: Anna Strang, MS, CGC
Target Audience
Pathologists and geneticists working with breast cancer samples
Modules 1, 2, and 4 recorded: December 2023
Module 3: January 2024
Expire from Catalog: February 1, 2025
Learners will be awarded a Certificate of Attendance at the conclusion of the course.
CME or CMLE credits are NOT available for this educational series.
This educational content was co-developed and funded by AstraZeneca and MSD. The authors, reviewers, and editors of these educational materials have made extensive efforts to ensure that treatments, diagnostics and discussions about medical practice are accurate and conform to the standards accepted at the time of publication. However, constant changes in information resulting from continuing research and clinical experience, reasonable differences in opinions among authorities, unique aspects of individual clinical situations, and the possibility of human error in preparing a series of educational materials mean that other sources of medical information may differ from the information on this site. The reader is advised to also consult local medical sources. Z4-61620; Date of preparation: February 2024.
This educational curriculum is not supported by CME points.
